Kamyar Asadipooya, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Blueprint Medicines Corporation
    Topic:
    An oral presentation about Systemic Mastocytosis and Skeletal Complications, they paid $1538.00
    Date added:
    02/05/2026
    Date updated:
    02/05/2026
    Relationship end date:
    12/01/2025
Return to Endocrine Tumor Board 3/23/2026